Hematology-Oncology
Lee, Jeeyun
95 AppointmentProfessor, Division of Hem/Oncology, Samsung Medical Center
Speciality Interests
Schedule
09 | TUE 10 |
WEN 11 |
THU 12 |
FRI 13 |
MON 16 |
---|---|---|---|---|---|
AM | available | available | |||
PM |
Medical School
2005 Ph.D. in Medicine Graduate School of Sungkyunkwan University, Korea 2002 Master of Science Graduate School of Sungkyunkwan University, Korea 1999 College of Medicine, Ewha Womans University, Korea
Specialty Training
Fellowship | 2004~2005 Clinical Fellowship in Hematology-Oncology, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea | |
---|---|---|
Residency | 2000~2003 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea | |
Internship | 1999~2000 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea |
Other Education
2022~present Director Precision Oncology Center, Samsung Medical Center
2019~present Director Experimental Therapeutics Development Center, Samsung Medical Center
2019~2022 Member Member of Samsung Future Technology Meeting Committee, Korea
2020~present Professor Department of Intelligence Precision Convergence Engineering, SKKU, Suwon
2020~ Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2014~2020 Associate Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2010~2014 Assistant Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2006~2010 Clinical Assistant Professor Division of Hem/Oncology, Samsung Medical Center
2006~2008 Visiting Scientist Sidney Kimmel Cancer Center, San Diego, CA, USA
2005.07 completed AACR Workshop in Cancer Research: Molecular Biology in Clinical Oncology
2004.08 completed Australia and Asia Pacific Clinical Oncology Research Development Workshop: A Workshop in Effective Clinical Trials Design
Participation in Academic Societies
and Research
Present Member American Society of Clinical Oncology
Present Member AACR
Present Member Korean Association of Clinical Oncology
Thesis
EUR RADIOL 2021 10.1007/s00330-021-08094-3
Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer
CANCERS 2021 10.3390/cancers13102316
Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer
NATURE 2021 10.1038/s41586-021-03515-1
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
JAMA ONCOL 2021 10.1001/jamaoncol.2021.0275
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
J DERMATOL 2021 10.1111/1346-8138.15824
Clinical profile of cutaneous adverse events of immune checkpoint inhibitors in a single tertiary center